These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 14688041)

  • 21. Epidemiology of extended-spectrum beta-lactamase producing gram-negative bacilli at Siriraj Hospital, Thailand, 2003.
    Chayakulkeeree M; Junsriwong P; Keerasuntonpong A; Tribuddharat C; Thamlikitkul V
    Southeast Asian J Trop Med Public Health; 2005 Nov; 36(6):1503-9. PubMed ID: 16610653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended-spectrum beta-lactamase-producing Enterobacteriaceae strains in community-acquired bacteremia in Southern Israel.
    Borer A; Gilad J; Menashe G; Peled N; Riesenberg K; Schlaeffer F
    Med Sci Monit; 2002 Jan; 8(1):CR44-7. PubMed ID: 11791130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid.
    Tamayo J; Orden B; Cacho J; Cuadros J; Gomez-Garces JL; Alos JI
    Rev Esp Quimioter; 2007 Sep; 20(3):334-8. PubMed ID: 18080031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
    Henshke-Bar-Meir R; Yinnon AM; Rudensky B; Attias D; Schlesinger Y; Raveh D
    Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulation of a multiresistant, conjugative, IncA/C plasmid within the nosocomial Providencia stuartii population in the Athens area.
    Giakkoupi P; Tryfinopoulou K; Polemis M; Pappa O; Miriagou V; Vatopoulos A
    Diagn Microbiol Infect Dis; 2015 May; 82(1):62-4. PubMed ID: 25752202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection.
    Rodríguez-Baño J; Alcalá J; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
    J Antimicrob Chemother; 2009 Apr; 63(4):781-4. PubMed ID: 19223299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First report on the occurrence of SHV-12 extended-spectrum beta-lactamase-producing Enterobacteriaceae in the Philippines.
    Cabrera EC; Rodriguez RD
    J Microbiol Immunol Infect; 2009 Feb; 42(1):74-85. PubMed ID: 19424562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and molecular analysis of extended-spectrum {beta}-lactamase-producing enterobacteria in the community setting.
    Arpin C; Dubois V; Maugein J; Jullin J; Dutilh B; Brochet JP; Larribet G; Fischer I; Quentin C
    J Clin Microbiol; 2005 Oct; 43(10):5048-54. PubMed ID: 16207960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First detection of TEM-116 extended-spectrum β-lactamase in a Providencia stuartii isolate from a Tunisian hospital.
    Lahlaoui H; Dahmen S; Moussa MB; Omrane B
    Indian J Med Microbiol; 2011; 29(3):258-61. PubMed ID: 21860106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting.
    Arpin C; Quentin C; Grobost F; Cambau E; Robert J; Dubois V; Coulange L; André C;
    J Antimicrob Chemother; 2009 Jun; 63(6):1205-14. PubMed ID: 19329798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek University Hospital.
    Souli M; Kontopidou FV; Papadomichelakis E; Galani I; Armaganidis A; Giamarellou H
    Clin Infect Dis; 2008 Mar; 46(6):847-54. PubMed ID: 18269335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp.: a nested case-control study from a tertiary hospital in London.
    Skippen I; Shemko M; Turton J; Kaufmann ME; Palmer C; Shetty N
    J Hosp Infect; 2006 Oct; 64(2):115-23. PubMed ID: 16859810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nosocomial dissemination of plasmids carrying blaTEM-24, blaDHA-1, aac(6')-Ib-cr, and qnrA6 in Providencia spp. strains isolated from a Tunisian hospital.
    Mahrouki S; Chihi H; Bourouis A; Ayari K; Ferjani M; Moussa MB; Belhadj O
    Diagn Microbiol Infect Dis; 2015 Jan; 81(1):50-2. PubMed ID: 25315769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose cefepime as an alternative treatment for infections caused by TEM-24 ESBL-producing Enterobacter aerogenes in severely-ill patients.
    Goethaert K; Van Looveren M; Lammens C; Jansens H; Baraniak A; Gniadkowski M; Van Herck K; Jorens PG; Demey HE; Ieven M; Bossaert L; Goossens H
    Clin Microbiol Infect; 2006 Jan; 12(1):56-62. PubMed ID: 16460547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit.
    Bagattini M; Crivaro V; Di Popolo A; Gentile F; Scarcella A; Triassi M; Villari P; Zarrilli R
    J Antimicrob Chemother; 2006 May; 57(5):979-82. PubMed ID: 16531430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ertapenem susceptibility of extended spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care centre in India.
    Behera B; Mathur P; Das A; Kapil A
    Singapore Med J; 2009 Jun; 50(6):628-32. PubMed ID: 19551319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended-spectrum beta-lactamase (ESBL)-producing enterobacteria: factors associated with infection in the community setting, Auckland, New Zealand.
    Moor CT; Roberts SA; Simmons G; Briggs S; Morris AJ; Smith J; Heffernan H
    J Hosp Infect; 2008 Apr; 68(4):355-62. PubMed ID: 18353497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular epidemiology and antimicrobial susceptibility of extended- and broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated in Portugal.
    Mendonça N; Ferreira E; Louro D; ; Caniça M
    Int J Antimicrob Agents; 2009 Jul; 34(1):29-37. PubMed ID: 19272757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory investigation of a suspected outbreak caused by Providencia stuartii with intermediate resistance to imipenem at a long-term care facility.
    Mao YC; Chang CL; Huang YC; Su LH; Lee CT
    J Microbiol Immunol Infect; 2018 Apr; 51(2):214-219. PubMed ID: 27553450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surveillance of multidrug-resistant gram-negative bacilli in a neonatal intensive care unit: prominent role of cross transmission.
    Mammina C; Di Carlo P; Cipolla D; Giuffrè M; Casuccio A; Di Gaetano V; Plano MR; D'Angelo E; Titone L; Corsello G
    Am J Infect Control; 2007 May; 35(4):222-30. PubMed ID: 17482993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.